A new modification of anti-tubercular active molecules
- 1 April 2007
- journal article
- Published by Elsevier BV in Bioorganic & Medicinal Chemistry
- Vol. 15 (7), 2551-2559
- https://doi.org/10.1016/j.bmc.2007.01.051
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Synthesis of pyrazinamide Mannich bases and its antitubercular propertiesBioorganic & Medicinal Chemistry Letters, 2006
- New drug candidates and therapeutic targets for tuberculosis therapyDrug Discovery Today, 2006
- Synthesis and in vitro and in vivo antimycobacterial activity of isonicotinoyl hydrazonesBioorganic & Medicinal Chemistry Letters, 2005
- Recent Advances in New Structural Classes of Anti-Tuberculosis AgentsCurrent Medicinal Chemistry, 2005
- Synthesis of isonicotinic acid N′-arylidene-N-[2-oxo-2-(4-aryl-piperazin-1-yl)-ethyl]-hydrazides as antituberculosis agentsBioorganic & Medicinal Chemistry Letters, 2005
- Prospects for new antitubercular drugsCurrent Opinion in Microbiology, 2004
- Mode of action of pyrazinamide: disruption of Mycobacterium tuberculosis membrane transport and energetics by pyrazinoic acidJournal of Antimicrobial Chemotherapy, 2003
- Tuberculosis Drug TargetsCurrent Drug Targets, 2002
- Activity of a new class of isonicotinoylhydrazones used alone and in combination with isoniazid, rifampicin, ethambutol, para-aminosalicylic acid and clofazimine against Mycobacterium tuberculosisJournal of Antimicrobial Chemotherapy, 2002
- InhA, a target of the antituberculous drug isoniazid, is involved in a mycobacterial fatty acid elongation system, FAS-IIMicrobiology, 2000